| IDSEP100006-01-00 (B. Tarbet - PI) |
09/30/2010 - 09/29/2015 |
Influenza Vaccine Biomanufacturing Training |
NIAID/NIH |
| HHSN272201100019I/HHSN27200016/B23, (D. Smee - PI) |
03/01/2016 - 09/30/2016 |
Zika Antiviral Screening Assays |
NIAID/NIH |
| HHSN272201100019I/HHSN27200015/B22, (D. Smee - PI) |
09/30/2015 - 09/29/2016 |
Comprehensive Viral Screening Panel |
NIAID/NIH |
| HHSN272201100019I/HHSN27200014/B21, (D. Smee - PI) |
07/20/2015 - 07/19/2016 |
In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses |
NIAID/NIH |
| HHSN272201100019I/HHSN27200013/B20, (D. Smee - PI) |
10/01/2014 - 09/30/2015 |
Supplement to Comprehensive Panel for Viruses |
NIAID/NIH |
| HHSN272201100019I/HHSN27200012/B19, (D. Smee - PI) |
09/01/2014 - 08/31/2015 |
Ebola Replicon Screen |
NIAID/NIH |
| HHSN272201100019I/HHSN27200011/B18, (D. Smee - PI) |
10/01/2014 - 09/30/2015 |
Ebola, Enterovirus-68 and Enterovirus-71 Screens |
NIAID/NIH |
| HHSN272201100019I/HHSN27200010/B17, Task B17 (D. Smee - PI) |
09/01/2014 - 08/30/2015 |
In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses |
NIAID/NIH |
| HHSN272201100019I/HHSN27200009/B16, Task B16 (D. Smee - PI) |
10/01/2014 - 09/30/2015 |
Comprehensive Panel for Viruses |
NIAID/NIH |
| HHSN272201100019I/, Task B13 (D. Smee - PI) |
09/01/2013 - 08/31/2014 |
In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses |
NIAID/NIH |
| HHSN272201100019I/HHSN27200008/B12, Task B12 (D. Smee - PI) |
10/01/2013 - 09/30/2014 |
Comprehensive Panel for Viruses |
NIAID/NIH |
| HHSN272201100019I/HHSN27200006/B10, Task B10 (D. Smee - PI) |
10/01/2011 - 09/30/2012 |
In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses |
NIAID/NIH |
| HHSN272201100019I/HHSN27200004/B09, Task B09 (D. Smee - PI) |
10/01/2011 - 09/30/2012 |
Comprehensive Panel for Viruses |
NIAID/NIH |
| HHSN272201100019I/HHSN27200003/B07, Task B07 (D. Smee - PI) |
10/01/2011 - 11/30/2012 |
Comprehensive Viruses Panel 2 |
NIAID/NIH |
| HHSN272201100019I/HHSN27200002/B05, Task B05 (D. Smee - PI) |
10/01/2011 - 09/30/2012 |
Respiratory Panel for Viruses |
NIAID/NIH |
| HHSN272201100019I/HHSN27200001/B01, Task B01 (D. Smee - PI) |
10/01/2011 - 09/30/2012 |
In Vitro Assessment for Antimicrobial Activity |
NIAID/NIH |
| HHSN272201000039I/HHSN27200015/A90, (J. Morrey - PI) |
01/11/2016 - 01/10/2017 |
Small Animal Models for Biodefense Viruses |
NIAID/NIH |
| HHSN272201000039I/HHSN27200015/A87, (J. Morrey - PI) |
09/15/2015 - 09/14/2016 |
Mouse Models for Evaluation of Influenza Vaccines and Vaccination Strategies |
NIAID/NIH |
| HHSN272201000039I/HHSN27200014/A86, (J. Morrey - PI) |
09/15/2015 - 9/14/2016 |
Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential |
NIAID/NIH |
| HHSN272201000039I/HHSN27200013/A79, (J. Morrey - PI) |
08/30/2015 - 08/29/2017 |
Mouse Model Development of Enteroviruses EV-D68 and EV-71 for Therapeutics |
NIAID/NIH |
| HHSN272201000039I/HHSN27200012/A66 Task A66 (J. Morrey - PI) |
09/09/2013 - 09/08/2014 |
Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics |
NIAID/NIH |
| HHSN272201000039I/HHSN27200011/A59 Task A59 (J. Morrey - PI) |
09/09/2013 - 09/08/2014 |
Mouse Models for Orthopoxviruses |
NIAID/NIH |
| HHSN272201000039I, Task A57 (J. Morrey - PI) |
09/15/2013 - 03/14/2015 |
Mouse Models of Medical Countermeasures Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) |
NIAID/NIH |
| HHSN272201000039I/HHSN27200008/A56 Task A56 (J. Morrey - PI) |
09/09/2013 - 09/08/2014 |
Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics |
NIAID/NIH |
| HHSN272201000039I/HHSN27200008/A44 Task A44 (J. Morrey - PI) |
09/09/2013 - 09/08/2014 |
Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics |
NIAID/NIH |
| HHSN272201000039I/HHSN27200007/A43 Task A43 (J. Morrey - PI) |
09/09/2013 - 09/08/2014 |
Mouse Models for Orthopoxviruses |
NIAID/NIH |
| HHSN272201000039I/HHSN27200005/A37 Task A37 (J. Morrey - PI) |
09/09/2013 - 09/08/2014 |
Mouse Models for Low Pathogenic Seasonal and Pandemic Influenza Viruses for Therapeutics |
NIAID/NIH |
| HHSN272201000039I/HHSN27200006/A30 Task A30 (J. Morrey - PI) |
09/09/2013 - 09/08/2014 |
Mouse Models for Orthopoxviruses |
NIAID/NIH |
| HHSN272201000039I, Task A21 (J. Morrey - PI) |
01/19/2011 - 01/18/2016 |
Small Animal Models for Biodefense Viruses and Prions |
NIAID/NIH |
| HHSN272201000039I, Task A19 (J. Morrey - PI) |
09/27/2010 - 09/26/2015 |
Human Hepatitis B Virus (HBV) Mouse Models for Testing HBV Therapeutics |
NIAID/NIH |
| HHSN272201000039I, Task A15 (J. Morrey - PI) |
09/27/2010 - 09/26/2015 |
Mouse Models for Evaluation of Influenza Vaccines and Adjuvants |
NIAID/NIH |
| 5R33AI101483-04S1, (J. Morrey - PI) |
03/01/2016 - 07/31/2017 |
Zika Virus Intrauterine Infection |
NIAID/NIH |
| 5R33AI101483-04, (J. Morrey - PI) |
08/01/2015 - 07/31/2016 |
Targeting Induction of Cystosolic Calcium buffers for Treatment of Viral Encephalitis |
NIAID/NIH |
| 2U54 AI065357/ Sub-award G-7822-1 (B. Gowen - PI) |
05/01/2009 - 04/30/2014 |
T-705 Pyrazine Derivative Treatment of Highly Pathogenic Arenaviral Infections |
Rocky Mountain RCE/NIAID/NIH |
| 2U54 AI065357/ Sub-award G-7820-1 (J. Morrey - PI) |
05/01/2009 - 04/30/2014 |
Treatment of Acute West Nile Virus Disease and Neurological Sequelae |
Rocky Mountain RCE/NIAID/NIH |
| 2R44AI092916-02 (B. Tarbet - PI) |
07/01/2012 - 6/30/2014 |
Robust, Defined, Animal-Free Cell Culture Medium for the Production of Vaccines |
NIAID/NIH |
| 1R21NS090133-01A1, (J. Morrey - PI) |
07/01/2015 - 06/30/2016 |
Identifying Deficits in Brainstem Respiratory Circuits During viral Encephalitis |
NIAID/NIH |
| 1R21NS088400, (J. Morrey - PI) |
05/01/2015 - 04/30/2016 |
Cellular Mechanisms of Fatal Respiratory Insuffieciency in Arboviral Encephalitis |
NIAID/NIH |
| 1R21AI101483-01 (J. Morrey - PI) |
06/01/2012 - 05/31/2014 |
Targeting Induction of Cytosolic Calcium Buffers for Treatment of Viral Encephalitis |
NIAID/NIH |
